Trial
NCT00457951
A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Jazz Pharmaceuticals
Collaborators
—
Condition
Chronic Obstructive Pulmonary Disease
Intervention
Open-Label
Why stopped
Interim analysis: safety without efficacy ODSH in patients with acute COPD.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-12-02